Foundation Resource Management Inc Gilead Sciences, Inc. Transaction History

Foundation Resource Management Inc

$626 Million
Q2 2024

A detailed history of Foundation Resource Management Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Foundation Resource Management Inc holds 207,133 shares of GILD stock, worth $17.4 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares

207,133

Previous 205,686 0.7%

Holding current value

$17.4 Million

Previous $15.1 Million 5.68%

% of portfolio

2.27%

Previous 2.37%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	BUY	$63.15 - $72.88 $91,378 - $105,457	1,447 Added 0.7%	207,133 $14.2 Million
Q1 2024 Apr 11, 2024	BUY	$71.58 - $87.29 $376,582 - $459,232	5,261 Added 2.62%	205,686 $15.1 Million
Q4 2023 Jan 10, 2024	BUY	$73.27 - $83.09 $309,639 - $351,138	4,226 Added 2.15%	200,425 $16.2 Million
Q3 2023 Oct 10, 2023	SELL	$73.94 - $80.67 $24,917 - $27,185	-337 Reduced 0.17%	196,199 $14.7 Million
Q2 2023 Jul 12, 2023	BUY	$76.01 - $86.7 $379,137 - $432,459	4,988 Added 2.6%	196,536 $15.1 Million
Q1 2023 Apr 11, 2023	BUY	$77.31 - $88.08 $227,909 - $259,659	2,948 Added 1.56%	191,548 $15.9 Million
Q4 2022 Jan 12, 2023	BUY	$62.32 - $89.47 $48,048 - $68,981	771 Added 0.41%	188,600 $16.2 Million
Q3 2022 Oct 13, 2022	BUY	$59.54 - $68.01 $531,751 - $607,397	8,931 Added 4.99%	187,829 $11.6 Million
Q2 2022 Jul 15, 2022	BUY	$57.72 - $65.01 $120,230 - $135,415	2,083 Added 1.18%	178,898 $11.1 Million
Q1 2022 Apr 12, 2022	BUY	$57.92 - $72.58 $819,741 - $1.03 Million	14,153 Added 8.7%	176,815 $10.5 Million
Q4 2021 Jan 21, 2022	SELL	$64.88 - $73.64 $10.6 Million - $12 Million	-162,662 Reduced 50.0%	162,662 $11.8 Million
Q4 2021 Jan 12, 2022	BUY	$64.88 - $73.64 $10.8 Million - $12.3 Million	167,172 Added 105.7%	325,324 $23.6 Million
Q3 2021 Oct 12, 2021	BUY	$67.69 - $73.03 $22,879 - $24,684	338 Added 0.21%	158,152 $11 Million
Q2 2021 Jul 13, 2021	BUY	$63.47 - $69.35 $444 - $485	7 Added 0.0%	157,814 $10.9 Million
Q1 2021 Apr 08, 2021	BUY	$60.0 - $68.46 $219,420 - $250,358	3,657 Added 2.37%	157,807 $10.2 Million
Q4 2020 Jan 13, 2021	BUY	$56.65 - $64.55 $195,839 - $223,149	3,457 Added 2.29%	154,150 $8.98 Million
Q3 2020 Oct 07, 2020	SELL	$62.1 - $78.08 $56,511 - $71,052	-910 Reduced 0.6%	150,693 $9.52 Million
Q2 2020 Jul 08, 2020	SELL	$72.34 - $84.0 $234,815 - $272,664	-3,246 Reduced 2.1%	151,603 $11.7 Million
Q1 2020 Apr 08, 2020	SELL	$62.63 - $80.22 $1.2 Million - $1.54 Million	-19,136 Reduced 11.0%	154,849 $11.6 Million
Q4 2019 Jan 08, 2020	SELL	$61.62 - $67.78 $3.21 Million - $3.53 Million	-52,024 Reduced 23.02%	173,985 $11.3 Million
Q3 2019 Oct 03, 2019	SELL	$62.51 - $69.0 $81,700 - $90,183	-1,307 Reduced 0.57%	226,009 $14.3 Million
Q2 2019 Jul 10, 2019	SELL	$61.87 - $69.38 $41,143 - $46,137	-665 Reduced 0.29%	227,316 $15.4 Million
Q1 2019 Apr 11, 2019	SELL	$62.53 - $70.05 $530,567 - $594,374	-8,485 Reduced 3.59%	227,981 $14.8 Million
Q4 2018 Jan 17, 2019	BUY	$60.54 - $79.0 $37,716 - $49,217	623 Added 0.26%	236,466 $14.8 Million
Q3 2018 Oct 02, 2018	SELL	$71.28 - $78.92 $59,162 - $65,503	-830 Reduced 0.35%	235,843 $18.2 Million
Q2 2018 Jul 11, 2018	BUY	$64.88 - $75.68 $286,834 - $334,581	4,421 Added 1.9%	236,673 $16.8 Million
Q1 2018 Apr 19, 2018	BUY	$72.84 - $88.8 $60,238 - $73,437	827 Added 0.36%	232,252 $17.5 Million
Q4 2017 Jan 10, 2018	SELL	$71.15 - $83.52 $82,818 - $97,217	-1,164 Reduced 0.5%	231,425 $16.6 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $16.8 Million - $19.9 Million	232,589	232,589 $18.8 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundation Resource Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foundation Resource Management Inc with notifications on news.

Account

Foundation Resource Management Inc Gilead Sciences, Inc. Transaction History